Celgene's Cancer Drug Gets Support

Celgene received a positive opinion for its pancreatic-cancer treatment Abraxane from a European committee, paving the way for potential approval of the treatment there.



from WSJ.com: US Business http://online.wsj.com/article/SB10001424052702304337404579213672925489090.html?mod=pls_whats_news_us_business_f

via IFTTT